Cookie Img
Translate In : View in English View in Spanish View in French View in German View in Italian View in Chinese (Simplified) View in Japanese View in Korean View in Arabic View in Portuguese
 
 
 
Home » Products » Anti Cancer Formulation » Cipla Everolimus 10 MG

Cipla Everolimus 10 MG



<< Previous   Cipla Everolimus 10 MG   Next >>
Product Description
Cipla Everolimus 10 MG

Product Code : 15


SPR ONCOCARE (P) LTD

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Other Products in 'Anti Cancer Formulation' category
Hepcinat
Hepcinat
zytiga
zytiga
Lenvatinib-10mg
Lenvatinib-10mg
Cabozantinib- 40mg
Cabozantinib- 40mg
Bandrone Lymfuda
Bandrone Lymfuda
Votrient
Votrient
 
View all products(54)
 
<< Back



Sofovir
Sofovir
Ledifos of Hetero
Ledifos of Hetero
Imatinib Mesylate Capsules
Imatinib Mesylate Capsules
Cipla Everolimus 10 MG
Cipla Everolimus 10 MG
Sofosbuvir  Natco
Sofosbuvir Natco
pomalidomide capsules-2mg
pomalidomide capsules-2mg
Rivaroxaban
Rivaroxaban
Resof-L
Resof-L
Erlotinib Tablet
Erlotinib Tablet
Geftinib Tablets
Geftinib Tablets
Cabozantinib- 60mg
Cabozantinib- 60mg
Bortenat Injection
Bortenat Injection
Dasatinib 100 mg
Dasatinib 100 mg
zytiga
zytiga
Afatinib
Afatinib
Dasatinib 70 mg
Dasatinib 70 mg
Vandetanib- 100mg
Vandetanib- 100mg
Hepawell
Hepawell
Floragest Bolus
Floragest Bolus
Arthisol
Arthisol
Baceft-TZ
Baceft-TZ
Anthelz-3000
Anthelz-3000
Baceft
Baceft
Aisure
Aisure
FENVEN TM -3000
FENVEN TM -3000
Bupaven
Bupaven
Floragest Powder
Floragest Powder
 
Contact Details
No. 12, 100 Feet, Ring Road, BSK 3rd Stage, Bengaluru - 560085, Karnataka, India
CONTACT - Mr. Shiva Prasad (CEO)

Send Inquiry Send SMS
IN China

Mail: yiruisha@hotmail.com
Mobile: 0086 10 57270002
 
Translate In : View in English View in Spanish View in French View in German View in Italian View in Chinese (Simplified) View in Japanese View in Korean View in Arabic View in Portuguese
SPR ONCOCARE All Rights Reserved.